Source link : https://www.newshealth.biz/health-news/ema-backs-approval-of-elahere-for-ovarian-cancer/
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ema-backs-approval-elahere-ovarian-cancer-2024a1000h5l?src=rss Author : Publish date : 2024-09-20 14:43:51 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2024-09-20 14:43:51
Copyright for syndicated content belongs to the linked Source.